US Stock MarketDetailed Quotes

HCW Biologics (HCWB)

Watchlist
  • 0.3460
  • -0.0062-1.76%
Close Apr 14 16:00 ET
2.33MMarket Cap-0.03P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

HCW Biologics (HCWB) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
5.87%-13.39M
-18.37%-3.36M
-10.71%-3.24M
32.49%-3.28M
2.50%-3.51M
36.81%-14.23M
27.21%-2.83M
47.64%-2.93M
48.23%-4.86M
0.94%-3.6M
Net income from continuing operations
73.49%-7.96M
121.32%719.23K
-16.71%-4.55M
87.38%-1.93M
70.58%-2.2M
-20.12%-30.02M
68.42%-3.37M
20.98%-3.9M
-254.99%-15.28M
-47.28%-7.47M
Operating gains losses
---5.2M
---5.38M
----
----
----
----
----
----
----
----
Depreciation and amortization
-12.04%1.04M
-77.01%156.94K
35.39%173.91K
124.67%291.92K
72.08%419.01K
4.33%1.18M
148.59%682.51K
-53.70%128.45K
-54.30%129.93K
-18.52%243.5K
Other non cash items
-247,976.79%-1.04M
---1.06M
---1
---131.13K
35,985.17%150K
74.99%-418
--0
--0
--0
-300.00%-418
Change In working capital
-120.45%-2.78M
17.09%-361.65K
-134.71%-213.43K
-100.45%-44.97K
-164.02%-2.16M
392.99%13.6M
-143.59%-436.19K
155.57%614.93K
281.91%10.05M
242.19%3.38M
-Change in receivables
-42.32%550.03K
-102.17%-1.51K
-389.05%-9.06K
-73.53%65.88K
-21.71%494.71K
185.29%953.56K
108.43%69.64K
209.28%3.13K
154.77%248.91K
283.03%631.87K
-Change in prepaid assets
-82.93%141.99K
-910.93%-20.91K
25.96%157.75K
-34.43%263.05K
-185.21%-257.89K
117.26%831.62K
-99.62%2.58K
162.25%125.24K
107.32%401.17K
66.02%302.64K
-Change in payables and accrued expense
-129.25%-3.47M
33.28%-339.23K
-174.42%-362.12K
-103.98%-373.91K
-196.00%-2.4M
633.30%11.87M
-141.45%-508.4K
159.33%486.56K
1,801.51%9.4M
247.65%2.5M
-Change in other current liabilities
--0
--0
--0
--0
--0
82.70%-56.54K
--0
--0
--0
28.63%-56.54K
Cash from discontinued investing activities
Operating cash flow
5.87%-13.39M
-18.37%-3.36M
-10.71%-3.24M
32.49%-3.28M
2.50%-3.51M
36.81%-14.23M
27.21%-2.83M
47.64%-2.93M
48.23%-4.86M
0.94%-3.6M
Investing cash flow
Cash flow from continuing investing activities
0
0
0
0
0
-106.89%-261.62K
96.95%-113.41K
-100.40%-37.06K
101.19%18.57K
56.82%-129.71K
Net PPE purchase and sale
--0
--0
--0
--0
--0
95.78%-261.62K
96.95%-113.41K
94.12%-37.06K
101.19%18.57K
56.82%-129.71K
Net investment purchase and sale
----
----
----
----
----
--0
--0
----
----
----
Cash from discontinued investing activities
Investing cash flow
--0
--0
--0
--0
--0
-106.89%-261.62K
96.95%-113.41K
-100.40%-37.06K
101.19%18.57K
56.82%-129.71K
Financing cash flow
Cash flow from continuing financing activities
-31.47%10.67M
-36.43%4.21M
-32.23%1.9M
140.18%4.61M
-101.26%-53.1K
107,217.90%15.57M
43,540.29%6.62M
31,576.24%2.8M
24,807.64%1.92M
222,022.78%4.22M
Net issuance payments of debt
-99.67%22.38K
-109.55%-32.85K
-101.12%-31.39K
-93.80%119.08K
-101.89%-32.46K
17,829.48%6.79M
1,274.35%343.99K
31,281.84%2.8M
--1.92M
--1.72M
Net common stock issuance
24.31%8.03M
15.27%4.57M
--1.99M
--1.47M
-99.93%1.65K
27,124.54%6.46M
28,105.20%3.96M
--0
--0
131,528.62%2.5M
Proceeds from stock option exercised by employees
29.23%3.82M
--0
----
----
----
--2.96M
--2.96M
----
----
----
Net other financing activities
-89.61%-1.21M
---321.38K
---63.5K
---802.6K
---22.3K
---638.05K
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-31.47%10.67M
-36.43%4.21M
-32.23%1.9M
140.18%4.61M
-101.26%-53.1K
107,217.90%15.57M
43,540.29%6.62M
31,576.24%2.8M
24,807.64%1.92M
222,022.78%4.22M
Net cash flow
Beginning cash position
30.03%4.67M
9.89%1.1M
110.02%2.44M
-72.88%1.11M
30.03%4.67M
-83.90%3.6M
-91.10%998.22K
-84.41%1.16M
-77.79%4.08M
-83.90%3.6M
Current changes in cash
-352.17%-2.72M
-76.73%855.56K
-722.88%-1.34M
145.55%1.33M
-829.48%-3.57M
105.76%1.08M
148.21%3.68M
-104.32%-163.09K
73.29%-2.92M
112.42%488.98K
End cash Position
-58.23%1.95M
-58.23%1.95M
9.89%1.1M
110.02%2.44M
-72.88%1.11M
30.03%4.67M
30.03%4.67M
-91.10%998.22K
-84.41%1.16M
-77.79%4.08M
Free cash flow
7.57%-13.39M
-13.81%-3.36M
-9.33%-3.24M
32.23%-3.28M
5.89%-3.51M
49.54%-14.49M
61.26%-2.95M
52.35%-2.96M
55.76%-4.84M
5.21%-3.73M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 5.87%-13.39M-18.37%-3.36M-10.71%-3.24M32.49%-3.28M2.50%-3.51M36.81%-14.23M27.21%-2.83M47.64%-2.93M48.23%-4.86M0.94%-3.6M
Net income from continuing operations 73.49%-7.96M121.32%719.23K-16.71%-4.55M87.38%-1.93M70.58%-2.2M-20.12%-30.02M68.42%-3.37M20.98%-3.9M-254.99%-15.28M-47.28%-7.47M
Operating gains losses ---5.2M---5.38M--------------------------------
Depreciation and amortization -12.04%1.04M-77.01%156.94K35.39%173.91K124.67%291.92K72.08%419.01K4.33%1.18M148.59%682.51K-53.70%128.45K-54.30%129.93K-18.52%243.5K
Other non cash items -247,976.79%-1.04M---1.06M---1---131.13K35,985.17%150K74.99%-418--0--0--0-300.00%-418
Change In working capital -120.45%-2.78M17.09%-361.65K-134.71%-213.43K-100.45%-44.97K-164.02%-2.16M392.99%13.6M-143.59%-436.19K155.57%614.93K281.91%10.05M242.19%3.38M
-Change in receivables -42.32%550.03K-102.17%-1.51K-389.05%-9.06K-73.53%65.88K-21.71%494.71K185.29%953.56K108.43%69.64K209.28%3.13K154.77%248.91K283.03%631.87K
-Change in prepaid assets -82.93%141.99K-910.93%-20.91K25.96%157.75K-34.43%263.05K-185.21%-257.89K117.26%831.62K-99.62%2.58K162.25%125.24K107.32%401.17K66.02%302.64K
-Change in payables and accrued expense -129.25%-3.47M33.28%-339.23K-174.42%-362.12K-103.98%-373.91K-196.00%-2.4M633.30%11.87M-141.45%-508.4K159.33%486.56K1,801.51%9.4M247.65%2.5M
-Change in other current liabilities --0--0--0--0--082.70%-56.54K--0--0--028.63%-56.54K
Cash from discontinued investing activities
Operating cash flow 5.87%-13.39M-18.37%-3.36M-10.71%-3.24M32.49%-3.28M2.50%-3.51M36.81%-14.23M27.21%-2.83M47.64%-2.93M48.23%-4.86M0.94%-3.6M
Investing cash flow
Cash flow from continuing investing activities 00000-106.89%-261.62K96.95%-113.41K-100.40%-37.06K101.19%18.57K56.82%-129.71K
Net PPE purchase and sale --0--0--0--0--095.78%-261.62K96.95%-113.41K94.12%-37.06K101.19%18.57K56.82%-129.71K
Net investment purchase and sale ----------------------0--0------------
Cash from discontinued investing activities
Investing cash flow --0--0--0--0--0-106.89%-261.62K96.95%-113.41K-100.40%-37.06K101.19%18.57K56.82%-129.71K
Financing cash flow
Cash flow from continuing financing activities -31.47%10.67M-36.43%4.21M-32.23%1.9M140.18%4.61M-101.26%-53.1K107,217.90%15.57M43,540.29%6.62M31,576.24%2.8M24,807.64%1.92M222,022.78%4.22M
Net issuance payments of debt -99.67%22.38K-109.55%-32.85K-101.12%-31.39K-93.80%119.08K-101.89%-32.46K17,829.48%6.79M1,274.35%343.99K31,281.84%2.8M--1.92M--1.72M
Net common stock issuance 24.31%8.03M15.27%4.57M--1.99M--1.47M-99.93%1.65K27,124.54%6.46M28,105.20%3.96M--0--0131,528.62%2.5M
Proceeds from stock option exercised by employees 29.23%3.82M--0--------------2.96M--2.96M------------
Net other financing activities -89.61%-1.21M---321.38K---63.5K---802.6K---22.3K---638.05K----------------
Cash from discontinued financing activities
Financing cash flow -31.47%10.67M-36.43%4.21M-32.23%1.9M140.18%4.61M-101.26%-53.1K107,217.90%15.57M43,540.29%6.62M31,576.24%2.8M24,807.64%1.92M222,022.78%4.22M
Net cash flow
Beginning cash position 30.03%4.67M9.89%1.1M110.02%2.44M-72.88%1.11M30.03%4.67M-83.90%3.6M-91.10%998.22K-84.41%1.16M-77.79%4.08M-83.90%3.6M
Current changes in cash -352.17%-2.72M-76.73%855.56K-722.88%-1.34M145.55%1.33M-829.48%-3.57M105.76%1.08M148.21%3.68M-104.32%-163.09K73.29%-2.92M112.42%488.98K
End cash Position -58.23%1.95M-58.23%1.95M9.89%1.1M110.02%2.44M-72.88%1.11M30.03%4.67M30.03%4.67M-91.10%998.22K-84.41%1.16M-77.79%4.08M
Free cash flow 7.57%-13.39M-13.81%-3.36M-9.33%-3.24M32.23%-3.28M5.89%-3.51M49.54%-14.49M61.26%-2.95M52.35%-2.96M55.76%-4.84M5.21%-3.73M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +8.11%
Sample Name
Sample Code
 +7.67%
Sample Name
Sample Code
 +5.06%
4
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.18%
5
United States Gasoline Fund Lp
UGA
+2.58%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +26.23%
Sample Name
Sample Code
 +21.09%
Sample Name
Sample Code
 +18.00%
4
Hesai
HSAI
+16.00%
5
Futu Holdings Ltd
FUTU
+14.80%
View More
Middle East conflict spreads to the stock market! How should investors respond?
US President Trump stated in a recent interview that the US war with Iran has 'ended.' According to Axios, Pakistan, Egypt, and Turkey have Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -